Industry Research Reports

Home > Reports > Medical Care > Cancer Screening Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Cancer Screening Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-12

Pages: 130 Pages

Report ld: 2625226

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Cancer Screening Technology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Cancer Screening Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cancer Screening Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Cancer Screening Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Cancer Screening Technology include Abbott, BD, Siemens Healthineers, GE Healthcare, F. Hoffmann-La Roche, Olympus Corporation, FUJIFILM Corporation, Agilent Technologies and Eiken Chemical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cancer Screening Technology by region & country, by Type, and by Application.

The Cancer Screening Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Technology.

Market Segmentation

Report Metric
Details
Report Title
Cancer Screening Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Cancer Screening Technology Companies Covered
Abbott, BD, Siemens Healthineers, GE Healthcare, F. Hoffmann-La Roche, Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics
Global Cancer Screening Technology Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Screening Technology Market, Segment by Type
Instrument-based Inspection

Platform-based Inspection
Global Cancer Screening Technology Market, Segment by Application
Lung Cancer Screening

Breast Cancer Screening

Prostate Cancer Screening

Colorectal Cancer Screening

Blood Cancer Screening

Liver Cancer Screening

Pancreatic Cancer Screening

Skin Cancer Screening

Cervical Cancer Screening

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cancer Screening Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cancer Screening Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cancer Screening Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Cancer Screening Technology Product Introduction
    1.2 Global Cancer Screening Technology Market Size Forecast
    1.3 Cancer Screening Technology Market Trends & Drivers
        1.3.1 Cancer Screening Technology Industry Trends
        1.3.2 Cancer Screening Technology Market Drivers & Opportunity
        1.3.3 Cancer Screening Technology Market Challenges
        1.3.4 Cancer Screening Technology Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Cancer Screening Technology Players Revenue Ranking (2023)
    2.2 Global Cancer Screening Technology Revenue by Company (2019-2024)
    2.3 Key Companies Cancer Screening Technology Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Cancer Screening Technology Product Offered
    2.5 Key Companies Time to Begin Mass Production of Cancer Screening Technology
    2.6 Cancer Screening Technology Market Competitive Analysis
        2.6.1 Cancer Screening Technology Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Cancer Screening Technology Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Technology as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Instrument-based Inspection
        3.1.2 Platform-based Inspection
    3.2 Global Cancer Screening Technology Sales Value by Type
        3.2.1 Global Cancer Screening Technology Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Cancer Screening Technology Sales Value, by Type (2019-2030)
        3.2.3 Global Cancer Screening Technology Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Lung Cancer Screening
        4.1.2 Breast Cancer Screening
        4.1.3 Prostate Cancer Screening
        4.1.4 Colorectal Cancer Screening
        4.1.5 Blood Cancer Screening
        4.1.6 Liver Cancer Screening
        4.1.7 Pancreatic Cancer Screening
        4.1.8 Skin Cancer Screening
        4.1.9 Cervical Cancer Screening
        4.1.10 Other
    4.2 Global Cancer Screening Technology Sales Value by Application
        4.2.1 Global Cancer Screening Technology Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Cancer Screening Technology Sales Value, by Application (2019-2030)
        4.2.3 Global Cancer Screening Technology Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Cancer Screening Technology Sales Value by Region
        5.1.1 Global Cancer Screening Technology Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Cancer Screening Technology Sales Value by Region (2019-2024)
        5.1.3 Global Cancer Screening Technology Sales Value by Region (2025-2030)
        5.1.4 Global Cancer Screening Technology Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Cancer Screening Technology Sales Value, 2019-2030
        5.2.2 North America Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Cancer Screening Technology Sales Value, 2019-2030
        5.3.2 Europe Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Cancer Screening Technology Sales Value, 2019-2030
        5.4.2 Asia Pacific Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Cancer Screening Technology Sales Value, 2019-2030
        5.5.2 South America Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Cancer Screening Technology Sales Value, 2019-2030
        5.6.2 Middle East & Africa Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Cancer Screening Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Cancer Screening Technology Sales Value
    6.3 United States
        6.3.1 United States Cancer Screening Technology Sales Value, 2019-2030
        6.3.2 United States Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Cancer Screening Technology Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Cancer Screening Technology Sales Value, 2019-2030
        6.4.2 Europe Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Cancer Screening Technology Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Cancer Screening Technology Sales Value, 2019-2030
        6.5.2 China Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Cancer Screening Technology Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Cancer Screening Technology Sales Value, 2019-2030
        6.6.2 Japan Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Cancer Screening Technology Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Cancer Screening Technology Sales Value, 2019-2030
        6.7.2 South Korea Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Cancer Screening Technology Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Cancer Screening Technology Sales Value, 2019-2030
        6.8.2 Southeast Asia Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Cancer Screening Technology Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Cancer Screening Technology Sales Value, 2019-2030
        6.9.2 India Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Cancer Screening Technology Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Profile
        7.1.2 Abbott Main Business
        7.1.3 Abbott Cancer Screening Technology Products, Services and Solutions
        7.1.4 Abbott Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.1.5 Abbott Recent Developments
    7.2 BD
        7.2.1 BD Profile
        7.2.2 BD Main Business
        7.2.3 BD Cancer Screening Technology Products, Services and Solutions
        7.2.4 BD Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.2.5 BD Recent Developments
    7.3 Siemens Healthineers
        7.3.1 Siemens Healthineers Profile
        7.3.2 Siemens Healthineers Main Business
        7.3.3 Siemens Healthineers Cancer Screening Technology Products, Services and Solutions
        7.3.4 Siemens Healthineers Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.3.5 GE Healthcare Recent Developments
    7.4 GE Healthcare
        7.4.1 GE Healthcare Profile
        7.4.2 GE Healthcare Main Business
        7.4.3 GE Healthcare Cancer Screening Technology Products, Services and Solutions
        7.4.4 GE Healthcare Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.4.5 GE Healthcare Recent Developments
    7.5 F. Hoffmann-La Roche
        7.5.1 F. Hoffmann-La Roche Profile
        7.5.2 F. Hoffmann-La Roche Main Business
        7.5.3 F. Hoffmann-La Roche Cancer Screening Technology Products, Services and Solutions
        7.5.4 F. Hoffmann-La Roche Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.5.5 F. Hoffmann-La Roche Recent Developments
    7.6 Olympus Corporation
        7.6.1 Olympus Corporation Profile
        7.6.2 Olympus Corporation Main Business
        7.6.3 Olympus Corporation Cancer Screening Technology Products, Services and Solutions
        7.6.4 Olympus Corporation Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.6.5 Olympus Corporation Recent Developments
    7.7 FUJIFILM Corporation
        7.7.1 FUJIFILM Corporation Profile
        7.7.2 FUJIFILM Corporation Main Business
        7.7.3 FUJIFILM Corporation Cancer Screening Technology Products, Services and Solutions
        7.7.4 FUJIFILM Corporation Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.7.5 FUJIFILM Corporation Recent Developments
    7.8 Agilent Technologies
        7.8.1 Agilent Technologies Profile
        7.8.2 Agilent Technologies Main Business
        7.8.3 Agilent Technologies Cancer Screening Technology Products, Services and Solutions
        7.8.4 Agilent Technologies Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.8.5 Agilent Technologies Recent Developments
    7.9 Eiken Chemical
        7.9.1 Eiken Chemical Profile
        7.9.2 Eiken Chemical Main Business
        7.9.3 Eiken Chemical Cancer Screening Technology Products, Services and Solutions
        7.9.4 Eiken Chemical Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.9.5 Eiken Chemical Recent Developments
    7.10 Hitachi Chemical (Kyowa Medex)
        7.10.1 Hitachi Chemical (Kyowa Medex) Profile
        7.10.2 Hitachi Chemical (Kyowa Medex) Main Business
        7.10.3 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Products, Services and Solutions
        7.10.4 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.10.5 Hitachi Chemical (Kyowa Medex) Recent Developments
    7.11 Clinical Genomics Pty Ltd (Quest Diagnostics)
        7.11.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Profile
        7.11.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Main Business
        7.11.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Products, Services and Solutions
        7.11.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.11.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
    7.12 Sysmex
        7.12.1 Sysmex Profile
        7.12.2 Sysmex Main Business
        7.12.3 Sysmex Cancer Screening Technology Products, Services and Solutions
        7.12.4 Sysmex Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.12.5 Sysmex Recent Developments
    7.13 QIAGEN
        7.13.1 QIAGEN Profile
        7.13.2 QIAGEN Main Business
        7.13.3 QIAGEN Cancer Screening Technology Products, Services and Solutions
        7.13.4 QIAGEN Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.13.5 QIAGEN Recent Developments
    7.14 R-Biopharm
        7.14.1 R-Biopharm Profile
        7.14.2 R-Biopharm Main Business
        7.14.3 R-Biopharm Cancer Screening Technology Products, Services and Solutions
        7.14.4 R-Biopharm Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.14.5 R-Biopharm Recent Developments
    7.15 Immunostics
        7.15.1 Immunostics Profile
        7.15.2 Immunostics Main Business
        7.15.3 Immunostics Cancer Screening Technology Products, Services and Solutions
        7.15.4 Immunostics Cancer Screening Technology Revenue (US$ Million) & (2019-2024)
        7.15.5 Immunostics Recent Developments

 8 Industry Chain Analysis
    8.1 Cancer Screening Technology Industrial Chain
    8.2 Cancer Screening Technology Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Cancer Screening Technology Sales Model
        8.5.2 Sales Channel
        8.5.3 Cancer Screening Technology Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Cancer Screening Technology Market Trends
    Table 2. Cancer Screening Technology Market Drivers & Opportunity
    Table 3. Cancer Screening Technology Market Challenges
    Table 4. Cancer Screening Technology Market Restraints
    Table 5. Global Cancer Screening Technology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cancer Screening Technology Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Cancer Screening Technology Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Cancer Screening Technology Product Type
    Table 9. Key Companies Time to Begin Mass Production of Cancer Screening Technology
    Table 10. Global Cancer Screening Technology Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Technology as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Cancer Screening Technology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Cancer Screening Technology Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Cancer Screening Technology Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Cancer Screening Technology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Cancer Screening Technology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Cancer Screening Technology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Cancer Screening Technology Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Cancer Screening Technology Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Cancer Screening Technology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Cancer Screening Technology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Cancer Screening Technology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Cancer Screening Technology Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Cancer Screening Technology Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Cancer Screening Technology Sales Value by Region (2019-2024) & (%)
    Table 27. Global Cancer Screening Technology Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Cancer Screening Technology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Cancer Screening Technology Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Cancer Screening Technology Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Basic Information List
    Table 32. Abbott Description and Business Overview
    Table 33. Abbott Cancer Screening Technology Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Cancer Screening Technology Business of Abbott (2019-2024)
    Table 35. Abbott Recent Developments
    Table 36. BD Basic Information List
    Table 37. BD Description and Business Overview
    Table 38. BD Cancer Screening Technology Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Cancer Screening Technology Business of BD (2019-2024)
    Table 40. BD Recent Developments
    Table 41. Siemens Healthineers Basic Information List
    Table 42. Siemens Healthineers Description and Business Overview
    Table 43. Siemens Healthineers Cancer Screening Technology Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Cancer Screening Technology Business of Siemens Healthineers (2019-2024)
    Table 45. Siemens Healthineers Recent Developments
    Table 46. GE Healthcare Basic Information List
    Table 47. GE Healthcare Description and Business Overview
    Table 48. GE Healthcare Cancer Screening Technology Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Cancer Screening Technology Business of GE Healthcare (2019-2024)
    Table 50. GE Healthcare Recent Developments
    Table 51. F. Hoffmann-La Roche Basic Information List
    Table 52. F. Hoffmann-La Roche Description and Business Overview
    Table 53. F. Hoffmann-La Roche Cancer Screening Technology Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Cancer Screening Technology Business of F. Hoffmann-La Roche (2019-2024)
    Table 55. F. Hoffmann-La Roche Recent Developments
    Table 56. Olympus Corporation Basic Information List
    Table 57. Olympus Corporation Description and Business Overview
    Table 58. Olympus Corporation Cancer Screening Technology Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Cancer Screening Technology Business of Olympus Corporation (2019-2024)
    Table 60. Olympus Corporation Recent Developments
    Table 61. FUJIFILM Corporation Basic Information List
    Table 62. FUJIFILM Corporation Description and Business Overview
    Table 63. FUJIFILM Corporation Cancer Screening Technology Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Cancer Screening Technology Business of FUJIFILM Corporation (2019-2024)
    Table 65. FUJIFILM Corporation Recent Developments
    Table 66. Agilent Technologies Basic Information List
    Table 67. Agilent Technologies Description and Business Overview
    Table 68. Agilent Technologies Cancer Screening Technology Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Cancer Screening Technology Business of Agilent Technologies (2019-2024)
    Table 70. Agilent Technologies Recent Developments
    Table 71. Eiken Chemical Basic Information List
    Table 72. Eiken Chemical Description and Business Overview
    Table 73. Eiken Chemical Cancer Screening Technology Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Cancer Screening Technology Business of Eiken Chemical (2019-2024)
    Table 75. Eiken Chemical Recent Developments
    Table 76. Hitachi Chemical (Kyowa Medex) Basic Information List
    Table 77. Hitachi Chemical (Kyowa Medex) Description and Business Overview
    Table 78. Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Cancer Screening Technology Business of Hitachi Chemical (Kyowa Medex) (2019-2024)
    Table 80. Hitachi Chemical (Kyowa Medex) Recent Developments
    Table 81. Clinical Genomics Pty Ltd (Quest Diagnostics) Basic Information List
    Table 82. Clinical Genomics Pty Ltd (Quest Diagnostics) Description and Business Overview
    Table 83. Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Cancer Screening Technology Business of Clinical Genomics Pty Ltd (Quest Diagnostics) (2019-2024)
    Table 85. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
    Table 86. Sysmex Basic Information List
    Table 87. Sysmex Description and Business Overview
    Table 88. Sysmex Cancer Screening Technology Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Cancer Screening Technology Business of Sysmex (2019-2024)
    Table 90. Sysmex Recent Developments
    Table 91. QIAGEN Basic Information List
    Table 92. QIAGEN Description and Business Overview
    Table 93. QIAGEN Cancer Screening Technology Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Cancer Screening Technology Business of QIAGEN (2019-2024)
    Table 95. QIAGEN Recent Developments
    Table 96. R-Biopharm Basic Information List
    Table 97. R-Biopharm Description and Business Overview
    Table 98. R-Biopharm Cancer Screening Technology Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Cancer Screening Technology Business of R-Biopharm (2019-2024)
    Table 100. R-Biopharm Recent Developments
    Table 101. Immunostics Basic Information List
    Table 102. Immunostics Description and Business Overview
    Table 103. Immunostics Cancer Screening Technology Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Cancer Screening Technology Business of Immunostics (2019-2024)
    Table 105. Immunostics Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Cancer Screening Technology Downstream Customers
    Table 109. Cancer Screening Technology Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Cancer Screening Technology Product Picture
    Figure 2. Global Cancer Screening Technology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cancer Screening Technology Sales Value (2019-2030) & (US$ Million)
    Figure 4. Cancer Screening Technology Report Years Considered
    Figure 5. Global Cancer Screening Technology Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Screening Technology Revenue in 2023
    Figure 7. Cancer Screening Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Instrument-based Inspection Picture
    Figure 9. Platform-based Inspection Picture
    Figure 10. Global Cancer Screening Technology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Cancer Screening Technology Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Lung Cancer Screening
    Figure 13. Product Picture of Breast Cancer Screening
    Figure 14. Product Picture of Prostate Cancer Screening
    Figure 15. Product Picture of Colorectal Cancer Screening
    Figure 16. Product Picture of Blood Cancer Screening
    Figure 17. Product Picture of Liver Cancer Screening
    Figure 18. Product Picture of Pancreatic Cancer Screening
    Figure 19. Product Picture of Skin Cancer Screening
    Figure 20. Product Picture of Cervical Cancer Screening
    Figure 21. Product Picture of Other
    Figure 22. Global Cancer Screening Technology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Cancer Screening Technology Sales Value Market Share by Application, 2023 & 2030
    Figure 24. North America Cancer Screening Technology Sales Value (2019-2030) & (US$ Million)
    Figure 25. North America Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    Figure 26. Europe Cancer Screening Technology Sales Value (2019-2030) & (US$ Million)
    Figure 27. Europe Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    Figure 28. Asia Pacific Cancer Screening Technology Sales Value (2019-2030) & (US$ Million)
    Figure 29. Asia Pacific Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    Figure 30. South America Cancer Screening Technology Sales Value (2019-2030) & (US$ Million)
    Figure 31. South America Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    Figure 32. Middle East & Africa Cancer Screening Technology Sales Value (2019-2030) & (US$ Million)
    Figure 33. Middle East & Africa Cancer Screening Technology Sales Value by Country (%), 2023 VS 2030
    Figure 34. Key Countries/Regions Cancer Screening Technology Sales Value (%), (2019-2030)
    Figure 35. United States Cancer Screening Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 36. United States Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
    Figure 37. United States Cancer Screening Technology Sales Value by Application (%), 2023 VS 2030
    Figure 38. Europe Cancer Screening Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Europe Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
    Figure 40. Europe Cancer Screening Technology Sales Value by Application (%), 2023 VS 2030
    Figure 41. China Cancer Screening Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 42. China Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
    Figure 43. China Cancer Screening Technology Sales Value by Application (%), 2023 VS 2030
    Figure 44. Japan Cancer Screening Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Japan Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
    Figure 46. Japan Cancer Screening Technology Sales Value by Application (%), 2023 VS 2030
    Figure 47. South Korea Cancer Screening Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 48. South Korea Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
    Figure 49. South Korea Cancer Screening Technology Sales Value by Application (%), 2023 VS 2030
    Figure 50. Southeast Asia Cancer Screening Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Southeast Asia Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
    Figure 52. Southeast Asia Cancer Screening Technology Sales Value by Application (%), 2023 VS 2030
    Figure 53. India Cancer Screening Technology Sales Value, (2019-2030) & (US$ Million)
    Figure 54. India Cancer Screening Technology Sales Value by Type (%), 2023 VS 2030
    Figure 55. India Cancer Screening Technology Sales Value by Application (%), 2023 VS 2030
    Figure 56. Cancer Screening Technology Industrial Chain
    Figure 57. Cancer Screening Technology Manufacturing Cost Structure
    Figure 58. Channels of Distribution (Direct Sales, and Distribution)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation

Description

The global market for Cancer Screening Technology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Cancer Screening Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cancer Screening Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Cancer Screening Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Cancer Screening Technology include Abbott, BD, Siemens Healthineers, GE Healthcare, F. Hoffmann-La Roche, Olympus Corporation, FUJIFILM Corporation, Agilent Technologies and Eiken Chemical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cancer Screening Technology by region & country, by Type, and by Application.

The Cancer Screening Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Technology.

Market Segmentation